These two case reports exemplify two extremes in the spectrum of adverse allergic reactions to naproxen, a non-selective COX-I and COX-II inhibitor, one systemic, the second localized and suggest that the pathogenesis of these symptoms was most likely pseudo-allergic in nature and not immunologically-mediated.